Literature DB >> 29043593

Fecal Calprotectin in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.

Cong Dai1, Min Jiang2, Ming-Jun Sun2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29043593     DOI： 10.1007/s10620-017-4799-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

1.  Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.

Authors:  Javier P Gisbert; Fernando Bermejo; Jose-Lázaro Pérez-Calle; Carlos Taxonera; Isabel Vera; Adrian G McNicholl; Alicia Algaba; Pilar López; Natalia López-Palacios; Marta Calvo; Yago González-Lama; Jose-Antonio Carneros; Marta Velasco; José Maté
Journal:  Inflamm Bowel Dis       Date:  2009-08       Impact factor: 5.325

2.  Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy.

Authors:  Rocio Ferreiro-Iglesias; Manuel Barreiro-de Acosta; Manuel Otero Santiago; Aurelio Lorenzo Gonzalez; Carmen Alonso de la Peña; Alfonso J Benitez Estevez; Juan Enrique Dominguez-Muñoz
Journal:  J Clin Gastroenterol       Date:  2016-02       Impact factor: 3.062

3.  Impact of disease location on fecal calprotectin levels in Crohn's disease.

Authors:  Krisztina B Gecse; Johannan F Brandse; Sandra van Wilpe; Mark Löwenberg; Cyriel Ponsioen; Gijs van den Brink; Geert D'Haens
Journal:  Scand J Gastroenterol       Date:  2015-01-30       Impact factor: 2.423

4.  Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.

Authors:  Anna-Maija Puolanne; Kaija-Leena Kolho; Henrik Alfthan; Ari Ristimäki; Harri Mustonen; Martti Färkkilä
Journal:  Dig Dis Sci       Date:  2017-09-25       Impact factor: 3.199

5.  Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.

Authors:  Erik Mooiweer; Mirjam Severs; Marguerite E I Schipper; Herma H Fidder; Peter D Siersema; Robert J F Laheij; Bas Oldenburg
Journal:  J Crohns Colitis       Date:  2014-11-26       Impact factor: 9.071

6.  The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis.

Authors:  Anders Lasson; Per-Ove Stotzer; Lena Öhman; Stefan Isaksson; Maria Sapnara; Hans Strid
Journal:  J Crohns Colitis       Date:  2015-01       Impact factor: 9.071

7.  Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.

Authors:  Dorota Walkiewicz; Steven L Werlin; Daryl Fish; Mathew Scanlon; Patrick Hanaway; Subra Kugathasan
Journal:  Inflamm Bowel Dis       Date:  2008-05       Impact factor: 5.325
  7 in total
  1 in total

1.  Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial.

Authors:  Maribel Botana-Rial; Lorena Vázquez-Iglesias; Pedro Casado-Rey; María Páez de la Cadena; María Amalia Andrade-Olivié; José Abal-Arca; Laura García-Nimo; Lucía Ferreiro-Fernández; Luis Valdés-Cuadrado; María Esther San-José; Francisco Javier Rodríguez-Berrocal; Alberto Fernández-Villar
Journal:  Sci Rep       Date:  2020-03-30       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.